Legal Representation
Attorney
Dyan M. House
USPTO Deadlines
Next Deadline
126 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200505)
Due Date
May 05, 2026
Grace Period Ends
November 05, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 5, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| May 5, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 1, 2020 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
| Mar 9, 2020 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Apr 1, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 9, 2020 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
| Mar 6, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 6, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 6, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 6, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 6, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 10, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 16, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 16, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 26, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 12, 2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 10, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 10, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 10, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 10, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Apr 10, 2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Apr 10, 2019 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Apr 10, 2019 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 26, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 26, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 25, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 19, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 17, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 17, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 17, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 13, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 2, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 26, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations in the nature of cardiovascular treatments, treatments for macular degeneration and ocular disease; agents for medical purposes for the treatment of diseases and medical conditions, namely, for the treatment of cardiovascular disease and ocular disease
Class 010
Surgical apparatus and instruments; surgical apparatus for medical, dental or veterinary use; medical and surgical apparatus and instruments for use in cardiovascular surgery; medical and surgical apparatus and instruments for use in ocular surgery; medical and surgical implants made of artificial materials; medical cutting devices; medical devices for use in treating or diagnosing cardiovascular disease; medical devices for use in treating or diagnosing ocular disease
Class 036
Providing financial assistance services for healthcare purposes; charitable foundation services, namely, providing financial assistance for programs and services of others
Class 042
Biomedical research services; biotechnology research; research and development in pharmaceutical and biotechnology fields; research and development in respect of medical devices; development of new technology for others in the field of biotechnology; conducting clinical trials for others; research and development in respect of surgical and medical instruments and devices; research and development in respect of medical products; medical research and development in the field of cardiovascular disease and treatment; medical research and development in the field of ocular disease and treatment
Additional Information
Pseudo Mark
MEDICAL MEN
Classification
International Classes
005
010
036
042